The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma

被引:28
作者
Hartmann, Sylvia [1 ,2 ]
Pluetschow, Annette [3 ,4 ]
Mottok, Anja [5 ,6 ,7 ,8 ]
Bernd, Heinz-Wolfram [9 ]
Feller, Alfred C. [9 ]
Ott, German [10 ]
Cogliatti, Sergio [11 ]
Fend, Falko [12 ]
Quintanilla-Martinez, Leticia [12 ]
Stein, Harald [13 ]
Klapper, Wolfram [14 ]
Moeller, Peter [15 ]
Rosenwald, Andreas [5 ,6 ]
Engert, Andreas [3 ,4 ]
Hansmann, Martin-Leo [1 ,2 ,16 ]
Eichenauer, Dennis A. [3 ,4 ]
机构
[1] Goethe Univ, Senckenberg Inst Pathol, Frankfurt, Germany
[2] Goethe Univ, Reference & Consultat Ctr Lymph Node & Lymphoma P, Frankfurt, Germany
[3] Univ Cologne, Ctr Integrated Oncol Aachen Bonn Cologne Dusseldo, Dept Internal Med 1, Cologne, Germany
[4] Univ Hosp Cologne, German Hodgkin Study Grp, Cologne, Germany
[5] Univ Wurzburg, Inst Pathol, Wurzburg, Germany
[6] Comprehens Canc Ctr CCC Mainfranken, Wurzburg, Germany
[7] Ulm Univ, Inst Human Genet, Ulm, Germany
[8] Ulm Univ, Med Ctr, Ulm, Germany
[9] Hematopathol Lubeck, Lubeck, Germany
[10] Robert Bosch Krankenhaus & Dr Margarete Fischer B, Dept Clin Pathol, Stuttgart, Germany
[11] Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland
[12] Eberhard Karls Univ Tubingen, Inst Pathol, Tubingen, Germany
[13] Berlin Reference Ctr Lymphoma & Hematopathol, Pathodiagnost Berlin, Berlin, Germany
[14] Univ Hosp Schleswig Holstein, Hematopathol Sect & Lymph Node Registry, Inst Pathol, Campus Kiel, Kiel, Germany
[15] Univ Hosp Ulm, Inst Pathol, Ulm, Germany
[16] Frankfurt Inst Adv Studies, Frankfurt, Germany
关键词
PROGNOSTIC IMPACT; TRANSFORMATION; DISEASE;
D O I
10.1002/ajh.25607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) can present with different histopathological growth patterns. The impact of these histopathological growth patterns on relapse characteristics is unknown. We therefore analyzed paired biopsies obtained at initial diagnosis and relapse from 33 NLPHL patients who had received first-line treatment within German Hodgkin Study Group (GHSG) trial protocols, and from a second cohort of 41 relapsed NLPHL patients who had been treated outside GHSG studies. Among the 33 GHSG patients, 21 patients presented with a typical growth pattern at initial diagnosis, whereas 12 patients had a variant histology. The histopathological growth patterns at initial diagnosis and at relapse were consistent in 67% of cases. A variant histology at initial diagnosis was associated with a shorter median time to lymphoma recurrence (2.8 vs 5.2 years; P = .0219). A similar tendency towards a shorter median time to lymphoma recurrence was observed for patients presenting with a variant histology at relapse, irrespective of the growth pattern at initial diagnosis. Results obtained from the 41 NLPHL patients who had been treated outside GHSG studies were comparable (median time to lymphoma recurrence for variant histology vs typical growth pattern at initial diagnosis: 1.5 vs 7.0 years). In conclusion, the histopathological growth pattern remains consistent at relapse in the majority of NLPHL cases, and has major impact on the time of relapse.
引用
收藏
页码:1208 / 1213
页数:6
相关论文
共 50 条
  • [1] Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma in the Modern Era
    King, Martin T.
    Donaldson, Sarah S.
    Link, Michael P.
    Natkunam, Yasodha
    Advani, Ranjana H.
    Hoppe, Richard T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (01): : 67 - 75
  • [2] Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)
    Allen, Pamela
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 : 30 - 33
  • [3] Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
    Borchmann, Sven
    Joffe, Erel
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    Noy, Ariela
    Portlock, Carol S.
    Gerecitano, John F.
    Batlevi, Connie L.
    Caron, Philip C.
    Drullinsky, Pamela
    Hamilton, Audrey
    Hamlin, Paul A., Jr.
    Horwitz, Steven M.
    Kumar, Anita
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Owens, Colette N.
    Palomba, M. Lia
    Younes, Anas
    Straus, David J.
    BLOOD, 2019, 133 (20) : 2121 - 2129
  • [4] Update on Nodular lymphocyte-Predominant Hodgkin lymphoma
    Eichenauer, Dennis
    TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 : 25 - 26
  • [5] Management of nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Engert, Andreas
    HEMATOLOGICAL ONCOLOGY, 2013, 31 : 47 - 50
  • [6] Treatment of nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Eich, Hans Theodor
    Engert, Andreas
    ONKOLOGIE, 2022, 28 (10): : 908 - 913
  • [7] Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma
    Spinner, Michael A.
    Varma, Gaurav
    Advani, Ranjana H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (01) : 17 - 29
  • [8] Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma
    Agbay, Rose Lou Marie C.
    Loghavi, Sanam
    Zuo, Zhuang
    Fayad, Luis
    Dabaja, Bouthaina
    Medeiros, L. Jeffrey
    Khoury, Joseph D.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (04) : 492 - 499
  • [9] Update on nodular lymphocyte predominant Hodgkin's lymphoma and related lesions
    Hartmann, S.
    Hansmann, M. -L.
    PATHOLOGE, 2017, 38 (01): : 3 - 10
  • [10] Coexisting and Clonally Identical Classic Hodgkin Lymphoma and Nodular Lymphocyte Predominant Hodgkin Lymphoma
    Song, Joo Y.
    Eberle, Franziska C.
    Xi, Liqiang
    Raffeld, Mark
    Rahma, Osama
    Wilson, Wyndham H.
    Dunleavy, Kieron
    Pittaluga, Stefania
    Jaffe, Elaine S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (05) : 767 - 772